Experts say the Trump administration's cancellation of more than $800 million in research focused on LGBTQ patients could harm public health.

Most Americans surveyed said they do not support the Trump administration’s recent cuts to staff and spending at federal health agencies.

The FDA has granted accelerated approval to Avmapki (avutometinib) plus Fakzynja (defactinib) for the treatment of KRAS-mutated, recurrent low-grade serous ovarian cancer.

The Trump administration has terminated National Institutes of Health (NIH) grants totaling more than $1.8 billion, and the National Cancer Institute (NCI) is among the top 5 institutes with the most ...

Despite a congressional mandate to expand care for veterans, internal Veterans Affairs messages obtained by ProPublica paint a stark portrait of how chaotic cost cutting has already imperiled tests of ...

Michael Rogers, associate commissioner for inspections and investigations at the FDA, said he will retire on May 14.

The risk of death from kidney cancer has decreased in the United States in recent years, but the risk varies by sex, race, and ethnicity, according to research published in The Oncologist.

About 156 million people in the US live in areas with unhealthy air, according to The American Lung Association’s annual "State of the Air" report.

Washington state’s attorney general alleges the Trump administration has violated a preliminary injunction intended to stop it from cutting research funding.

A financial toxicity tumor board has effectively reduced financial toxicity for cancer patients, researchers say.

A prognostic index can be used to identify patients with estrogen receptor (ER)-positive, HER2-negative early breast cancer who can safely forgo adjuvant chemotherapy as well as patients who require ...

We want you to take advantage of everything Cancer Therapy Advisor has to offer. To view unlimited content, log in or register for free.